MCID: MNN006
MIFTS: 39

Meninges Hemangiopericytoma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Meninges Hemangiopericytoma

MalaCards integrated aliases for Meninges Hemangiopericytoma:

Name: Meninges Hemangiopericytoma 12 14
Hemangiopericytoma of Meninges 12 69
Meningeal Hemangiopericytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4957
NCIt 46 C4660
SNOMED-CT 64 277522009
UMLS 69 C0349622

Summaries for Meninges Hemangiopericytoma

MalaCards based summary : Meninges Hemangiopericytoma, also known as hemangiopericytoma of meninges, is related to hemangiopericytoma, malignant and mesenchymal chondrosarcoma. An important gene associated with Meninges Hemangiopericytoma is STAT6 (Signal Transducer And Activator Of Transcription 6), and among its related pathways/superpathways are PI3K-Akt signaling pathway and MAPK signaling pathway. The drugs Doxorubicin and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and adrenal gland, and related phenotypes are cellular and growth/size/body region

Related Diseases for Meninges Hemangiopericytoma

Diseases related to Meninges Hemangiopericytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 87)
# Related Disease Score Top Affiliating Genes
1 hemangiopericytoma, malignant 30.7 HBA1 IGF2 NAB2 STAT6 VIM
2 mesenchymal chondrosarcoma 30.4 HEY1 NCOA2 VIM
3 meningioma, familial 29.0 CD34 EPB41L3 GFAP IGF2 TERT VIM
4 meningitis 10.6
5 slipped capital femoral epiphysis 10.5 IGF1 IGFBP3
6 primitive neuroectodermal tumor of the cervix uteri 10.5 GFAP VIM
7 cutaneous leiomyosarcoma 10.5 GFAP VIM
8 parachordoma 10.4 GFAP VIM
9 adenoid squamous cell carcinoma 10.4 HBA1 VIM
10 acid-labile subunit deficiency 10.4 IGF1 IGF2 IGFBP3
11 rhabdoid meningioma 10.4 GFAP VIM
12 laron syndrome 10.4 IGF1 IGF2 IGFBP3
13 hypoglycemic coma 10.4 IGF2 INS
14 silver-russell syndrome 10.3 IGF1 IGF2 IGFBP3
15 spindle cell rhabdomyosarcoma 10.3 GFAP NCOA2
16 angiomatous meningioma 10.3 GFAP HBA1 PLAUR
17 type 1 diabetes mellitus 2 10.3 IGF2 INS
18 secondary adrenal insufficiency 10.3 IGF1 IGFBP3 INS
19 primary hepatic neuroendocrine carcinoma 10.3 CHGA VIM
20 pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities 10.3 IGF1 IGFBP3 INS
21 rubeosis iridis 10.3 IGF1 IGF2 INS
22 pituitary adenoma 1, multiple types 10.3 IGF1 IGFBP3
23 endocrine pancreas disease 10.3 IGF1 IGF2 INS
24 hyperpituitarism 10.3 IGF1 IGFBP3 INS
25 pancreas disease 10.3 IGF1 IGF2 INS
26 cellular ependymoma 10.2 CHGA GFAP
27 syringocystadenoma papilliferum 10.2 GFAP VIM
28 hypopituitarism 10.2 IGF1 IGFBP3 INS
29 chordoid meningioma 10.2 CHGA GFAP VIM
30 clear cell meningioma 10.2 CHGA GFAP VIM
31 glucose metabolism disease 10.2 HBA1 IGF1 INS
32 fetal macrosomia 10.1 IGF1 IGF2 IGFBP3 INS
33 male reproductive organ cancer 10.1 CHGA IGF1 IGFBP3
34 intraventricular meningioma 10.1 F8 GFAP TERT
35 glomangiomyoma 10.1 CD34 VIM
36 acromegaly 10.1 IGF1 IGF2 IGFBP3 INS
37 insulin-like growth factor i 10.1 IGF1 IGF2 IGFBP3 INS
38 pineal region choriocarcinoma 10.1 CD34 IGF1
39 sternum cancer 10.1 CD34 VIM
40 ovary sarcoma 10.1 CD34 HBA1
41 hyperinsulinemic hypoglycemia, familial, 2 10.1 CHGA IGF2 INS
42 ovarian angiosarcoma 10.1 CD34 HBA1
43 small intestine leiomyosarcoma 10.1 CD34 IGF2
44 intravascular fasciitis 10.1 CD34 HBA1
45 small intestinal sarcoma 10.1 CD34 IGF2
46 malignant pineal area germ cell neoplasm 10.1 CD34 IGF1
47 thyroid angiosarcoma 10.1 CD34 HBA1
48 hypoglycemia 10.1
49 islet cell tumor 10.1 CHGA IGF2 INS
50 hyperinsulinism 10.1 IGF1 IGFBP3 INS

Graphical network of the top 20 diseases related to Meninges Hemangiopericytoma:



Diseases related to Meninges Hemangiopericytoma

Symptoms & Phenotypes for Meninges Hemangiopericytoma

MGI Mouse Phenotypes related to Meninges Hemangiopericytoma:

43 (show all 16)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.44 EPB41L3 CD34 GFAP CSF1R CACNA1A PLAUR
2 growth/size/body region MP:0005378 10.39 CSF1R CACNA1A CHGA GFAP NCOA2 PLAUR
3 homeostasis/metabolism MP:0005376 10.38 CACNA1A CD34 F8 CHGA GFAP CSF1R
4 behavior/neurological MP:0005386 10.37 CSF1R CACNA1A EPB41L3 GFAP NCOA2 PLAUR
5 mortality/aging MP:0010768 10.28 CSF1R CACNA1A EPB41L3 F8 CHGA GFAP
6 immune system MP:0005387 10.27 CSF1R CACNA1A CD34 F8 INS NCOA2
7 endocrine/exocrine gland MP:0005379 10.26 CSF1R CACNA1A EPB41L3 CHGA INS NCOA2
8 cardiovascular system MP:0005385 10.25 CHGA INS PLAUR LIG3 IGFBP3 IGF1
9 hematopoietic system MP:0005397 10.24 CSF1R CACNA1A CD34 F8 INS PLAUR
10 integument MP:0010771 10.13 CSF1R CACNA1A CD34 INS NCOA2 NAB2
11 nervous system MP:0003631 10.13 CSF1R CACNA1A EPB41L3 INS PLAUR LIG3
12 muscle MP:0005369 10.07 CACNA1A GFAP PLAUR LIG3 IGFBP3 IGF1
13 normal MP:0002873 9.91 CSF1R CACNA1A EPB41L3 INS NAB2 IGF1
14 reproductive system MP:0005389 9.77 CACNA1A EPB41L3 F8 CHGA CSF1R STAT6
15 renal/urinary system MP:0005367 9.7 CHGA INS PLAUR IGF2 IGFBP3 IGF1
16 respiratory system MP:0005388 9.28 CACNA1A PLAUR NAB2 STAT6 IGFBP3 IGF1

Drugs & Therapeutics for Meninges Hemangiopericytoma

Drugs for Meninges Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 131)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
4
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
5
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
6
Lenograstim Approved, Investigational Phase 3,Phase 2 135968-09-1
7
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
8
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
9
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
10
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
11
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
12
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
13
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
14
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
15 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
16 Alkylating Agents Phase 3,Phase 2,Phase 1
17 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
18 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
19 Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
20 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
21 Adjuvants, Anesthesia Phase 3
22 Analgesics Phase 3,Phase 1
23 Analgesics, Opioid Phase 3
24 Anesthetics Phase 3
25 Anesthetics, General Phase 3
26 Anesthetics, Intravenous Phase 3
27 Central Nervous System Depressants Phase 3
28 Liver Extracts Phase 3,Phase 1
29 Narcotics Phase 3
30 Peripheral Nervous System Agents Phase 3,Phase 1
31 Cholinergic Agents Phase 3,Phase 2
32 Cholinesterase Inhibitors Phase 3,Phase 2
33 Neurotransmitter Agents Phase 3,Phase 2
34 Nootropic Agents Phase 3,Phase 2
35 Anti-Infective Agents Phase 3,Phase 2,Phase 1,Not Applicable
36 Antimitotic Agents Phase 3,Phase 2,Phase 1
37 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
38 Antirheumatic Agents Phase 3,Phase 2,Phase 1
39 Etoposide phosphate Phase 3,Phase 2
40 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable
41 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
42 Cola Nutraceutical Phase 3,Phase 1
43
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
44
Temozolomide Approved, Investigational Phase 2,Phase 1 85622-93-1 5394
45
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
46
Bevacizumab Approved, Investigational Phase 2 216974-75-3
47
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
48
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
49
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
50
Gemcitabine Approved Phase 2 95058-81-4 60750

Interventional clinical trials:

(show top 50) (show all 60)

# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
3 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
4 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
5 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
6 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
7 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
8 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
9 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
10 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
11 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
12 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
13 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2 Sunitinib
14 Imatinib Mesylate in Treating Patients With Recurrent Meningioma Completed NCT00045734 Phase 2 imatinib mesylate
15 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
16 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
17 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
18 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2 Imatinib mesylate
19 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2 vatalanib
20 S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Completed NCT00217620 Phase 2 sorafenib
21 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
22 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
23 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
24 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
25 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
26 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
27 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
28 Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Completed NCT00025675 Phase 2 gefitinib
29 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
30 Proton Radiation For Meningiomas and Hemangiopericytomas Recruiting NCT01117844 Phase 1, Phase 2
31 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2 Gemcitabine Hydrochloride;Pazopanib Hydrochloride
32 Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes Recruiting NCT02815995 Phase 2 Durvalumab;Tremelimumab
33 Trial of Dasatinib in Advanced Sarcomas Active, not recruiting NCT00464620 Phase 2 Dasatinib
34 Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas Active, not recruiting NCT01125046 Phase 2
35 A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma Not yet recruiting NCT03016091 Phase 2 Pembrolizumab
36 S9624 Ifosfamide in Treating Patients With Meningeal Tumors Terminated NCT00003292 Phase 2 ifosfamide
37 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
38 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
39 Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Gluco Completed NCT01082926 Phase 1
40 Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Completed NCT00720174 Phase 1 Doxorubicin Hydrochloride
41 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
42 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
43 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
44 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
45 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
46 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
47 CC-5013 in Treating Patients With Recurrent Glioma Completed NCT00036894 Phase 1 lenalidomide
48 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
49 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
50 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel

Search NIH Clinical Center for Meninges Hemangiopericytoma

Genetic Tests for Meninges Hemangiopericytoma

Anatomical Context for Meninges Hemangiopericytoma

MalaCards organs/tissues related to Meninges Hemangiopericytoma:

38
Bone, Liver, Adrenal Gland, Lung, Heart

Publications for Meninges Hemangiopericytoma

Articles related to Meninges Hemangiopericytoma:

(show all 49)
# Title Authors Year
1
Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases. ( 27044772 )
2016
2
Gastric metastasis from malignant meningeal hemangiopericytoma. ( 27801496 )
2016
3
NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor. ( 26883114 )
2016
4
Meningeal Hemangiopericytoma in 33-Year-Old Female; a Case Report. ( 27799979 )
2016
5
Intracranial meningeal hemangiopericytoma: Recurrences at the initial and distant intracranial sites and extraneural metastases to multiple organs. ( 26171177 )
2015
6
Liver metastases from meningeal hemangiopericytoma. ( 25913235 )
2015
7
Living-Donor Liver Transplantation for Hepatic Metastasis FromA Meningeal Hemangiopericytoma: A Case Report. ( 26361698 )
2015
8
Meningeal hemangiopericytoma only diagnosed at the time of late bone metastasis. ( 24934329 )
2014
9
Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion. ( 24124145 )
2013
10
Optic nerve meningeal hemangiopericytoma: a clinicopathologic case report. ( 23294915 )
2013
11
Metastasis of intracranial meningeal hemangiopericytoma to thoracic spine 17A years after surgical excision: a case report. ( 23943153 )
2013
12
The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database. ( 22867893 )
2013
13
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. ( 23575898 )
2013
14
MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma. ( 22824994 )
2012
15
Intracranial meningeal hemangiopericytoma: 10A years experience of a tertiary care Institute. ( 22790838 )
2012
16
Recurrent meningeal hemangiopericytoma with multiple metastasis and hypoglycemia: a case report. ( 23024657 )
2012
17
Meningeal Hemangiopericytoma with Intracranial Metastases in an HIV-Positive Male: Case Report and Review of the Literature. ( 22666206 )
2012
18
Intracranial meningeal hemangiopericytoma metastatic to the scapula. ( 22229602 )
2012
19
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. ( 21558077 )
2011
20
The status of MGMT protein expression is a prognostic factor for meningeal hemangiopericytoma: a clinicopathologic and immunohistochemical study of 12 cases at a single institution. ( 21667225 )
2011
21
Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma. ( 20622667 )
2010
22
Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison. ( 20165866 )
2010
23
Multiple metastatic progression of meningeal hemangiopericytoma initially diagnosed as atypical meningioma with temporal bone invasion. ( 19201308 )
2009
24
Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy. ( 18459177 )
2008
25
Meningeal hemangiopericytoma manifesting as massive intracranial hemorrhage--two case reports. ( 16498220 )
2006
26
Bone metastasis of intracranial meningeal hemangiopericytoma. ( 15990973 )
2005
27
Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. ( 15668900 )
2004
28
Meningeal hemangiopericytoma with delayed multiple distant metastases. ( 15648288 )
2004
29
Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. ( 15042684 )
2004
30
Meningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case report. ( 15143990 )
2004
31
[Multiple extracranial metastases from a meningeal hemangiopericytoma and severe hypoglycemia: a case report]. ( 15227844 )
2004
32
Fine needle aspiration cytology of hepatic metastasis from a meningeal hemangiopericytoma. A case report. ( 12685202 )
2003
33
Fetal meningeal hemangiopericytoma. Case report. ( 12450048 )
2002
34
Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma. ( 11266526 )
2001
35
Four cases of meningeal hemangiopericytoma treated with surgery and radiotherapy. ( 11773263 )
2001
36
Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. ( 11322435 )
2001
37
Tc-99m MDP and Tl-201 scintigraphy in a case of metastatic meningeal hemangiopericytoma. ( 11711721 )
2001
38
[Contribution of immunohistochemistry and electron microscopy for the diagnosis of meningeal hemangiopericytomas. 15 case reports]. ( 11084416 )
2000
39
Pancreatic head mass from metastatic meningeal hemangiopericytoma. ( 18521297 )
2000
40
Meningeal hemangiopericytoma in childhood. ( 11003400 )
2000
41
Hepatic and pulmonary metastases from a meningeal hemangiopericytoma and severe hypoglycemia due to abnormal secretion of insulin-like growth factor: a case report. ( 10326704 )
1999
42
Radiotherapy of bone metastases of a spinal meningeal hemangiopericytoma. ( 9581183 )
1998
43
Metastatic meningeal hemangiopericytoma of thoracic spine. ( 9822848 )
1998
44
Management of recurrent meningeal hemangiopericytoma. ( 9587125 )
1998
45
The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. ( 9351573 )
1997
46
Meningeal hemangiopericytoma metastatic to the heart. ( 8776772 )
1996
47
Insulin-like growth factor II expression in primary meningeal hemangiopericytoma and its metastasis to the liver accompanied by hypoglycemia. ( 8760024 )
1996
48
The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma. ( 8858518 )
1996
49
Soft-tissue and meningeal hemangiopericytomas: an immunohistochemical and ultrastructural study. ( 2318483 )
1990

Variations for Meninges Hemangiopericytoma

Expression for Meninges Hemangiopericytoma

Search GEO for disease gene expression data for Meninges Hemangiopericytoma.

Pathways for Meninges Hemangiopericytoma

GO Terms for Meninges Hemangiopericytoma

Cellular components related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.91 CD34 CHGA F8 HBA1 IGF1 IGF2
2 endoplasmic reticulum lumen GO:0005788 9.62 F8 IGFBP3 INS PLAUR
3 platelet alpha granule lumen GO:0031093 9.33 F8 IGF1 IGF2
4 insulin-like growth factor ternary complex GO:0042567 8.96 IGF1 IGFBP3
5 insulin-like growth factor binding protein complex GO:0016942 8.62 IGF1 IGFBP3

Biological processes related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.71 IGF1 IGF2 IGFBP3 INS
2 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.65 IGF1 IGF2 INS
3 movement of cell or subcellular component GO:0006928 9.63 IGF1 PLAUR VIM
4 positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568 9.51 IGF1 IGFBP3
5 positive regulation of insulin receptor signaling pathway GO:0046628 9.49 IGF2 INS
6 negative regulation of blood vessel diameter GO:0097756 9.43 CHGA INS
7 positive regulation of glucose import GO:0046326 9.43 IGF1 INS TERT
8 Bergmann glial cell differentiation GO:0060020 9.37 GFAP VIM
9 positive regulation of mitotic nuclear division GO:0045840 9.33 IGF1 IGF2 INS
10 intermediate filament-based process GO:0045103 9.32 GFAP VIM
11 positive regulation of MAPK cascade GO:0043410 9.26 IGF1 IGF2 IGFBP3 INS
12 positive regulation of glycogen biosynthetic process GO:0045725 8.8 IGF1 IGF2 INS

Molecular functions related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 insulin receptor binding GO:0005158 9.13 IGF1 IGF2 INS
2 insulin-like growth factor receptor binding GO:0005159 8.8 IGF1 IGF2 INS
3 protein binding GO:0005515 10.11 CACNA1A CSF1R EPB41L3 F8 GFAP HBA1

Sources for Meninges Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....